ARTICLE | Strategy
Amortizing exploitable technology
July 31, 1995 7:00 AM UTC
Noteworthy
The benefits of exploiting an enabling technology that can be sold more than once are apparent in Alkermes Inc.'s strategy in developing its ProLease peptide drug delivery technology. ...